La Jolla, CA, United States of America

Christa C Chrovian

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 9.3

ph-index = 9

Forward Citations = 194(Granted Patents)


Location History:

  • San Diego, CA (US) (2011 - 2013)
  • La Jolla, CA (US) (2015 - 2023)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Christa C. Chrovian: Innovator in Pharmaceutical Compounds

Introduction: Christa C. Chrovian, based in La Jolla, California, is a prominent inventor with a remarkable portfolio of 22 patents. His work focuses on advancing pharmaceutical compounds, particularly those that modulate specific receptors vital for various disease treatments.

Latest Patents: Among his latest innovations are two notable patents. The first is directed toward P2X7 modulators, which includes compounds of Formulas (I, IIa, and IIb) and encompasses pharmaceutical compositions utilizing these compounds. The second patent involves substituted pyrazolo-pyridine amides designed for use as GluN2B receptor modulators. This invention highlights the potential for these compounds to be applied in therapeutic contexts, particularly for conditions linked to GluN2B receptor activity.

Career Highlights: Christa Chrovian is associated with Janssen Pharmaceutica NV, where he contributes significantly to the research and development of novel pharmaceutical solutions. His input in creating compounds that effectively target specific receptor pathways marks a significant advancement in the field of drug development.

Collaborations: Throughout his career, Chrovian has collaborated with notable professionals, including Michael Anthony Letavic and Akinola Soyode-Johnson. These partnerships have helped facilitate the development of innovative therapeutic compounds and strengthened research efforts within Janssen Pharmaceutica NV.

Conclusion: Christa C. Chrovian stands out as an influential inventor in the pharmaceutical industry, with a strong focus on innovative compounds that address critical medical needs. His extensive patent portfolio and collaborative efforts demonstrate his commitment to advancing healthcare through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…